false Q1 --12-31 2026-03-31 2026 0001786286 0001786286 2026-01-01 2026-03-31 0001786286 2026-03-31 0001786286 2025-12-31 0001786286 2025-01-01 2025-03-31 0001786286 ifrs-full:IssuedCapitalMember 2024-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-12-31 0001786286 ifrs-full:WarrantReserveMember 2024-12-31 0001786286 ifrs-full:RetainedEarningsMember 2024-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2024-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-12-31 0001786286 2024-12-31 0001786286 ifrs-full:IssuedCapitalMember 2025-03-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2025-03-31 0001786286 ifrs-full:WarrantReserveMember 2025-03-31 0001786286 ifrs-full:RetainedEarningsMember 2025-03-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2025-03-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2025-03-31 0001786286 2025-03-31 0001786286 ifrs-full:IssuedCapitalMember 2025-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2025-12-31 0001786286 ifrs-full:WarrantReserveMember 2025-12-31 0001786286 ifrs-full:RetainedEarningsMember 2025-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2025-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2025-12-31 0001786286 ifrs-full:IssuedCapitalMember 2025-01-01 2025-03-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2025-01-01 2025-03-31 0001786286 ifrs-full:WarrantReserveMember 2025-01-01 2025-03-31 0001786286 ifrs-full:RetainedEarningsMember 2025-01-01 2025-03-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2025-01-01 2025-03-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2025-01-01 2025-03-31 0001786286 ifrs-full:IssuedCapitalMember 2025-04-01 2025-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2025-04-01 2025-12-31 0001786286 ifrs-full:WarrantReserveMember 2025-04-01 2025-12-31 0001786286 ifrs-full:RetainedEarningsMember 2025-04-01 2025-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2025-04-01 2025-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2025-04-01 2025-12-31 0001786286 2025-04-01 2025-12-31 0001786286 ifrs-full:IssuedCapitalMember 2026-01-01 2026-03-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2026-01-01 2026-03-31 0001786286 ifrs-full:WarrantReserveMember 2026-01-01 2026-03-31 0001786286 ifrs-full:RetainedEarningsMember 2026-01-01 2026-03-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2026-01-01 2026-03-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2026-01-01 2026-03-31 0001786286 ifrs-full:IssuedCapitalMember 2026-03-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2026-03-31 0001786286 ifrs-full:WarrantReserveMember 2026-03-31 0001786286 ifrs-full:RetainedEarningsMember 2026-03-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2026-03-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2026-03-31 0001786286 DPRO:DragonflyInnovationsIncMember 2026-01-01 2026-03-31 0001786286 DPRO:DragonflyInnovationsUSAIncMember 2026-01-01 2026-03-31 0001786286 DPRO:DronelogicsSystemsIncMember 2026-01-01 2026-03-31 0001786286 DPRO:PreviouslyReportedMember 2025-01-01 2025-03-31 0001786286 DPRO:ReclassificationAdjustmentMember 2025-01-01 2025-03-31 0001786286 2025-01-01 2025-12-31 0001786286 DPRO:InventoryMember 2026-01-01 2026-03-31 0001786286 DPRO:InventoryMember 2025-01-01 2025-03-31 0001786286 ifrs-full:ComputerEquipmentMember 2024-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2024-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2024-12-31 0001786286 ifrs-full:VehiclesMember 2024-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2025-01-01 2025-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2025-01-01 2025-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2025-01-01 2025-12-31 0001786286 ifrs-full:VehiclesMember 2025-01-01 2025-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2025-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2025-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2025-12-31 0001786286 ifrs-full:VehiclesMember 2025-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2026-01-01 2026-03-31 0001786286 DPRO:FurnitureAndEquipmentMember 2026-01-01 2026-03-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2026-01-01 2026-03-31 0001786286 ifrs-full:VehiclesMember 2026-01-01 2026-03-31 0001786286 ifrs-full:ComputerEquipmentMember 2026-03-31 0001786286 DPRO:FurnitureAndEquipmentMember 2026-03-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2026-03-31 0001786286 ifrs-full:VehiclesMember 2026-03-31 0001786286 ifrs-full:PropertyPlantAndEquipmentMember 2026-01-01 2026-03-31 0001786286 ifrs-full:PropertyPlantAndEquipmentMember 2025-01-01 2025-03-31 0001786286 ifrs-full:RightofuseAssetsMember 2026-01-01 2026-03-31 0001786286 ifrs-full:RightofuseAssetsMember 2025-01-01 2025-03-31 0001786286 ifrs-full:BuildingsMember 2026-03-31 0001786286 ifrs-full:BuildingsMember 2025-12-31 0001786286 ifrs-full:BottomOfRangeMember 2026-03-31 0001786286 ifrs-full:TopOfRangeMember 2026-03-31 0001786286 ifrs-full:NotLaterThanOneYearMember 2026-03-31 0001786286 ifrs-full:NotLaterThanOneYearMember 2025-12-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2026-03-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2025-12-31 0001786286 DPRO:CommonStock1Member 2026-02-23 0001786286 DPRO:CommonStock1Member ifrs-full:WarrantsMember 2026-02-23 0001786286 2026-02-23 2026-02-23 0001786286 2026-02-23 0001786286 DPRO:BrokerWarrantsMember 2026-02-23 2026-02-23 0001786286 ifrs-full:OrdinarySharesMember 2026-02-23 2026-02-23 0001786286 ifrs-full:WarrantsMember 2026-02-23 2026-02-23 0001786286 DPRO:RestrictedStockUnitsMember 2025-01-01 2025-12-31 0001786286 DPRO:CommonStock1Member 2025-05-05 0001786286 2025-05-05 2025-05-05 0001786286 DPRO:BrokerWarrantsMember 2025-05-05 2025-05-05 0001786286 ifrs-full:OrdinarySharesMember 2025-05-05 2025-05-05 0001786286 ifrs-full:WarrantsMember 2025-05-05 2025-05-05 0001786286 ifrs-full:WarrantsMember 2025-05-05 0001786286 2025-05-05 0001786286 DPRO:OverallotmentSharesMember 2025-05-05 0001786286 DPRO:OverallotmentSharesMember 2025-05-05 2025-05-05 0001786286 DPRO:CommonStock1Member 2025-06-12 0001786286 2025-06-12 2025-06-12 0001786286 DPRO:BrokerWarrantsMember 2025-06-12 2025-06-12 0001786286 ifrs-full:OrdinarySharesMember 2025-06-12 2025-06-12 0001786286 ifrs-full:WarrantsMember 2025-06-12 2025-06-12 0001786286 DPRO:CommonStock1Member 2025-07-21 0001786286 2025-07-21 2025-07-21 0001786286 DPRO:BrokerWarrantsMember 2025-07-21 2025-07-21 0001786286 DPRO:CommonStock1Member 2025-07-21 2025-07-21 0001786286 DPRO:CommonStock1Member 2023-06-01 2023-06-30 0001786286 DPRO:StockOptionsMember 2026-01-01 2026-03-31 0001786286 DPRO:StockOptionsMember 2025-01-01 2025-03-31 0001786286 DPRO:RestrictedStockUnitsMember 2026-01-01 2026-03-31 0001786286 DPRO:RestrictedStockUnitsMember 2025-01-01 2025-03-31 0001786286 ifrs-full:WarrantsMember 2026-01-01 2026-03-31 0001786286 ifrs-full:WarrantsMember 2025-01-01 2025-03-31 0001786286 ifrs-full:WarrantsMember 2024-12-31 0001786286 ifrs-full:WarrantsMember 2025-01-01 2025-12-31 0001786286 ifrs-full:WarrantsMember 2025-12-31 0001786286 ifrs-full:WarrantsMember 2026-03-31 0001786286 DPRO:ExercisePriceOneMember DPRO:IncentiveShareCompensationPlanMember 2026-01-01 2026-03-31 0001786286 DPRO:ExercisePriceOneMember DPRO:IncentiveShareCompensationPlanMember 2026-03-31 0001786286 DPRO:ExercisePriceTwoMember DPRO:IncentiveShareCompensationPlanMember 2026-01-01 2026-03-31 0001786286 DPRO:ExercisePriceTwoMember DPRO:IncentiveShareCompensationPlanMember 2026-03-31 0001786286 DPRO:ExercisePriceThreeMember DPRO:IncentiveShareCompensationPlanMember 2026-01-01 2026-03-31 0001786286 DPRO:ExercisePriceThreeMember DPRO:IncentiveShareCompensationPlanMember 2026-03-31 0001786286 DPRO:ExercisePriceFourMember DPRO:IncentiveShareCompensationPlanMember 2026-01-01 2026-03-31 0001786286 DPRO:ExercisePriceFourMember DPRO:IncentiveShareCompensationPlanMember 2026-03-31 0001786286 DPRO:ExercisePriceFiveMember DPRO:IncentiveShareCompensationPlanMember 2026-01-01 2026-03-31 0001786286 DPRO:ExercisePriceFiveMember DPRO:IncentiveShareCompensationPlanMember 2026-03-31 0001786286 DPRO:ExercisePriceSixMember DPRO:IncentiveShareCompensationPlanMember 2026-01-01 2026-03-31 0001786286 DPRO:ExercisePriceSixMember DPRO:IncentiveShareCompensationPlanMember 2026-03-31 0001786286 DPRO:ExercisePriceSevenMember DPRO:IncentiveShareCompensationPlanMember 2026-01-01 2026-03-31 0001786286 DPRO:ExercisePriceSevenMember DPRO:IncentiveShareCompensationPlanMember 2026-03-31 0001786286 DPRO:ExercisePriceEightMember DPRO:IncentiveShareCompensationPlanMember 2026-01-01 2026-03-31 0001786286 DPRO:ExercisePriceEightMember DPRO:IncentiveShareCompensationPlanMember 2026-03-31 0001786286 DPRO:IncentiveShareCompensationPlanMember 2026-03-31 0001786286 ifrs-full:RestrictedShareUnitsMember 2025-12-31 0001786286 ifrs-full:RestrictedShareUnitsMember 2026-01-01 2026-03-31 0001786286 ifrs-full:RestrictedShareUnitsMember 2026-03-31 0001786286 DPRO:BrokerMember DPRO:FebruaryIssuanceMember 2026-01-01 2026-03-31 0001786286 DPRO:BrokerMember DPRO:MayIssuanceMember 2025-01-01 2025-12-31 0001786286 DPRO:BrokerMember DPRO:JuneIssuanceMember 2025-01-01 2025-12-31 0001786286 DPRO:BrokerMember DPRO:JulyIssuanceMember 2025-01-01 2025-12-31 0001786286 ifrs-full:WarrantsMember 2024-12-31 0001786286 ifrs-full:WarrantsMember 2024-01-01 2024-12-31 0001786286 ifrs-full:WarrantsMember 2025-12-31 0001786286 ifrs-full:WarrantsMember 2026-01-01 2026-03-31 0001786286 ifrs-full:WarrantsMember 2026-03-31 0001786286 DPRO:RangeOneMember 2026-01-01 2026-03-31 0001786286 DPRO:RangeOneMember 2026-03-31 0001786286 DPRO:RangeOneMember 2025-12-31 0001786286 DPRO:RangeTwoMember 2026-01-01 2026-03-31 0001786286 DPRO:RangeTwoMember 2026-03-31 0001786286 DPRO:RangeTwoMember 2025-12-31 0001786286 DPRO:WarrantOneMember 2026-01-01 2026-03-31 0001786286 DPRO:WarrantOneMember 2026-03-31 0001786286 DPRO:WarrantTwoMember 2026-01-01 2026-03-31 0001786286 DPRO:WarrantTwoMember 2026-03-31 0001786286 DPRO:WarrantThreeMember 2026-01-01 2026-03-31 0001786286 DPRO:WarrantThreeMember 2026-03-31 0001786286 DPRO:WarrantFourMember 2026-01-01 2026-03-31 0001786286 DPRO:WarrantFourMember 2026-03-31 0001786286 DPRO:WarrantFiveMember 2026-01-01 2026-03-31 0001786286 DPRO:WarrantFiveMember 2026-03-31 0001786286 DPRO:WarrantSixMember 2026-01-01 2026-03-31 0001786286 DPRO:WarrantSixMember 2026-03-31 0001786286 DPRO:DronesMember 2026-01-01 2026-03-31 0001786286 DPRO:CorporatesMember 2026-01-01 2026-03-31 0001786286 DPRO:DronesMember 2025-01-01 2025-03-31 0001786286 DPRO:CorporatesMember 2025-01-01 2025-03-31 0001786286 DPRO:CAMember 2026-03-31 0001786286 DPRO:CAMember 2025-12-31 0001786286 DPRO:USCountryMember 2026-03-31 0001786286 DPRO:USCountryMember 2025-12-31 0001786286 DPRO:CAMember 2026-01-01 2026-03-31 0001786286 DPRO:CAMember 2025-01-01 2025-03-31 0001786286 DPRO:USCountryMember 2026-01-01 2026-03-31 0001786286 DPRO:USCountryMember 2025-01-01 2025-03-31 0001786286 DPRO:BusinessServicesAgreementMember DPRO:BusinessInstinctsGroupMember 2026-01-01 2026-03-31 0001786286 DPRO:BusinessServicesAgreementMember DPRO:BusinessInstinctsGroupMember 2025-01-01 2025-03-31 0001786286 DPRO:BusinessServicesAgreementMember DPRO:BusinessInstinctsGroupMember 2026-03-31 0001786286 DPRO:BusinessServicesAgreementMember DPRO:BusinessInstinctsGroupMember 2025-03-31 0001786286 DPRO:IndependentConsultantAgreementMember DPRO:AlbertaLtdMember 2026-01-01 2026-03-31 0001786286 DPRO:IndependentConsultantAgreementMember DPRO:AlbertaLtdMember 2025-01-01 2025-03-31 0001786286 DPRO:IndependentConsultantAgreementMember DPRO:AlbertaLtdMember 2026-03-31 0001786286 DPRO:IndependentConsultantAgreementMember DPRO:AlbertaLtdMember 2025-03-31 0001786286 DPRO:ExecutiveConsultantAgreementMember DPRO:ScottLarsonMember 2026-01-01 2026-03-31 0001786286 DPRO:ExecutiveConsultantAgreementMember DPRO:ScottLarsonMember 2025-01-01 2025-03-31 0001786286 DPRO:CEOAndDirectorMember 2026-01-01 2026-03-31 0001786286 DPRO:CEOAndDirectorMember 2025-01-01 2025-03-31 0001786286 DPRO:CEOMember 2026-01-01 2026-03-31 0001786286 DPRO:CEOMember 2025-01-01 2025-03-31 0001786286 DPRO:SalaryAndCommissionMember 2026-01-01 2026-03-31 0001786286 DPRO:SalaryAndCommissionMember 2025-01-01 2025-03-31 0001786286 DPRO:DirectorsMember 2026-01-01 2026-03-31 0001786286 DPRO:DirectorsMember 2025-01-01 2025-03-31 0001786286 ifrs-full:OtherRelatedPartiesMember 2026-01-01 2026-03-31 0001786286 ifrs-full:OtherRelatedPartiesMember 2025-01-01 2025-03-31 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2026-03-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2026-03-31 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2025-12-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2025-12-31 0001786286 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember 2026-01-01 2026-03-31 0001786286 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember 2025-01-01 2025-12-31 0001786286 DPRO:NonadjustingEventsMember 2026-04-15 2026-04-15 0001786286 DPRO:NonadjustingEventsMember ifrs-full:RestrictedShareUnitsMember 2026-04-15 2026-04-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure DPRO:Segments iso4217:CAD xbrli:shares iso4217:CAD

 

Exhibit 99.1

 

 

Draganfly Inc.

Condensed Consolidated Interim Financial Statements - Unaudited

For the Three Months Ended March 31, 2026

(Expressed in Canadian Dollars)

 

 

 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Financial Position

Expressed in Canadian Dollars

 

 

       March 31,   December 31, 
As at  Notes   2026   2025 
             
ASSETS               
Current Assets               
Cash       $147,339,721   $90,156,821 
Receivables   4    1,156,922    1,041,582 
Inventory   5    7,711,812    3,903,139 
Prepaids and Deposits   6    3,356,456    4,757,100 
Total current assets        159,564,911    99,858,642 
                
Non-current Assets               
Equipment   7    1,314,092    1,192,074 
Intangible assets        34,307    36,112 
Investments        28,571    71,429 
Right of use assets   8    193,935    229,616 
TOTAL ASSETS       $161,135,816   $101,387,873 
                
LIABILITIES AND SHAREHOLDERS’ EQUITY               
Current Liabilities               
Trade payables and accrued liabilities   10,16   $4,260,247   $3,397,343 
Customer deposits        317,034    417,641 
Deferred income   11    176,663    165,237 
Derivative liability   12    329,101    492,470 
Lease liabilities   9    125,926    143,624 
Total current liabilities        5,208,971    4,616,315 
                
Non-current Liabilities               
Deferred Income   11    37,428    44,512 
Lease liabilities   9    106,977    130,251 
TOTAL LIABILITIES        5,353,376    4,791,078 
                
SHAREHOLDERS’ EQUITY               
Share capital   12    291,374,851    229,698,507 
Reserves - share-based payments   12    10,568,042    7,347,457 
Reserves - warrants        126,534    126,534 
Accumulated deficit        (146,075,774)   (140,446,908)
Accumulated other comprehensive loss        (211,213)   (128,795)
TOTAL SHAREHOLDERS’ EQUITY        155,782,440    96,596,795 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY       $161,135,816   $101,387,873 

 

Subsequent event (Note 18)

 

Approved and authorized for issuance by the Board of Directors on May 11, 2026.

 

“Kim Moody”   “Cameron Chell”
Director   Director

 

2

 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Comprehensive Loss - Unaudited

Expressed in Canadian Dollars

 

 

       March 31, 2026   March 31, 2025 
       For the three months ended 
       March 31, 2026   March 31, 2025 
             
Sales of goods   13   $2,232,132   $1,541,811 
Provision of services   13    80,221    5,904 
TOTAL REVENUE        2,312,353    1,547,715 
                
COST OF SALES   5    (1,964,592)   (1,237,627)
                
GROSS PROFIT        347,761    310,088 
                
OPERATING EXPENSES               
Amortization       $1,805   $2,257 
Depreciation   7,8    121,251    75,416 
Director fees   16    119,498    132,651 
Insurance        228,118    155,749 
Office and miscellaneous   14    1,886,108    704,519 
Professional fees        603,159    415,120 
Research and development        628,638    161,886 
Share-based payments   12,16    244,064    288,883 
Travel        629,568    125,008 
Employee and management costs   16    3,501,014    1,849,546 
Total operating expenses        (7,963,223)   (3,911,035)
OTHER INCOME               
Change in fair value of derivative liability   12    1,047,731    157,830 
Finance and other costs        678,152    34,031 
Foreign exchange gain (loss)        2,694,532    (17,240)
Gain on disposal of assets        (6,371)   - 
Gain on recovery of notes receivable        -    25,951 
Other expense   15    (2,427,448)   (24,450)
 Total Other operating income       $1,986,596   $176,122 
                
NET LOSS       $(5,628,866)  $(3,424,825)
OTHER COMPREHENSIVE LOSS               
Items that may be reclassified to profit or loss               
Foreign exchange translation        (39,561)   (16,060)
Items that will not be reclassified to profit or loss               
Change in fair value of equity investments at FVOCI        (42,857)   7,173 
COMPREHENSIVE LOSS        (5,711,284)   (3,433,712)
                
Net Loss per share – Basic & diluted       $(0.17)  $(0.63)
Weighted average number of common shares outstanding – Basic & diluted        32,371,209    5,427,795 

 

3

 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity - Unaudited

Expressed in Canadian Dollars

 

 

   Number of Shares   Share Capital   Reserve – Share-Based Payments  

 

 

 

Reserves – Warrants

   Accumulated Deficit   Change in Fair Value of Investments at FVTOCI   Exchange Differences on Translation of Foreign Operations   Total Shareholders’ Equity 
                       Accumulated Other Comprehensive Income (Loss) 
   Number of Shares   Share Capital   Reserve – Share-Based Payments  

 

 

 

Reserves – Warrants

   Accumulated Deficit   Change in Fair Value of Investments at FVTOCI   Exchange Differences on Translation of Foreign Operations   Total Shareholders’ Equity 
Balance at December 31, 2024   5,427,795   $110,742,984   $7,698,304   $3,776,428   $(117,465,829)  $(609,420)  $479,316   $4,621,783 
Share issue costs   -    (306)   -    -    -    -    -    (306)
Shares issued for the exercise of RSUs   6,029    480,100    (480,100)   -    -    -    -    - 
Share-based payments   -    -    288,883    -    -    -    -    288,883 
Net loss   -    -    -    -    (3,424,825)   -    -    (3,424,825)
Change in fair value of equity investments at FVOCI   -    -    -    -    -    7,173    -    7,173 
Translation of foreign operations   -    -    -    -    -    -    (16,060)   (16,060)
Balance at March 31, 2025   5,433,824   $111,222,778   $7,507,087   $3,776,428   $(120,890,654)  $(602,247)  $463,256   $1,476,648 
Shares issued - overallotment   100,000    294,000    -    -    -    -    -    294,000 
Share issue costs - overallotment   -    (28,030)   -    -    -    -    -    (28,030)
Shares issued for financing   11,887,895    56,907,745    -    -    -    -    -    56,907,745 
Share issue costs   -    (7,328,625)   2,225,727    -    -    -    -    (5,102,898)
Shares issued for the exercise of warrant   11,712,347    67,861,616    (2,716,408)   (4,753,719)   -    -    -    60,391,489 
Shares issued for the exercise of RSUs   210,709    769,023    (769,023)   -    -    -    -    - 
Warrants – equity treatment   -    -    -    1,103,825    -    -    -    1,103,825 
Share-based payments   -    -    1,100,074    -    -    -    -    1,100,074 
Net loss   -    -    -    -    (19,556,254)   -    -    (19,556,254)
Change in fair value of equity investments at FVOCI   -    -    -    -    -    57,113    -    57,113 
Translation of foreign operations   -    -    -    -    -    -    (46,917)   (46,917)
Balance at December 31, 2025   29,344,775   $229,698,507   $7,347,457   $126,534   $(140,446,908)  $(545,134)  $416,339   $96,596,795 
Shares issued for financing   5,030,000    48,033,503    -    -    -    -    -    48,033,503 
Share issue costs        (5,724,416)   2,976,521    -    -    -    -    (2,747,895)
Shares issued for the exercise of warrant   2,121,164    19,367,257    -    -    -    -    -    19,367,257 
Share-based payments   -    -    244,064    -    -    -    -    244,064 
Net loss   -    -    -    -    (5,628,866)   -    -    (5,628,866)
Unrealized gain on investments available for sale   -    -    -    -    -    (42,857)   -    (42,857)
Other comprehensive income (loss)   -    -    -    -    -         (39,561)   (39,561)
Balance at March 31, 2026   36,495,939   $291,374,851   $10,568,042   $126,534   $(146,075,774)  $(587,991)  $376,778   $155,782,440 

 

4

 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Cash Flows - Unaudited

Expressed in Canadian Dollars

 

 

   March 31, 2026   March 31, 2025 
   For the three months ended 
   March 31, 2026   March 31, 2025 
         
OPERATING ACTIVITIES          
Net loss  $(5,628,866)  $(3,424,825)
Adjustments for:          
Amortization   1,805    2,257 
Depreciation   121,251    75,416 
Impairment of accounts receivable   (18,020)   186,440 
Change in fair value of derivative liability   (1,047,731)   (157,830)
Impairment (recovery) of inventory   105,840    (38,666)
Impairment (Gain) on recovery of notes receivable   -    (25,951)
Finance and other costs   2,412,431    (306)
Gain on disposal of assets   2,472    - 
Share-based payments   244,064    288,883 
Adjustments for profit loss   (3,806,754)   (3,094,582)
Net changes in non-cash working capital items:          
Receivables   (97,320)   (190,719)
Inventory   (3,902,630)   (385,650)
Prepaids   1,400,644    (454,793)
Trade payables and accrued liabilities   (1,871,188)   85,162 
Customer deposits   (100,607)   (39,768)
Deferred income   4,342    13,704 
Cash used in operating activities   (8,373,513)   (4,066,646)
           
INVESTING ACTIVITIES          
Purchase of equipment   (221,942)   (32,427)
Repayment of notes receivable   -    25,951 
Cash provided by (used in) investing activities   (221,942)   (6,476)
           
FINANCING ACTIVITIES          
Proceeds from issuance of common shares for financing   68,277,951    - 
Share issue costs   (5,160,327)   - 
Proceeds from issuance of common shares for warrants exercised   7,171    - 
Repayment of lease liabilities   (40,972)   (37,124)
Cash provided by (used in) financing activities   63,083,823    (37,124)
           
Effects of exchange rate changes on cash   2,694,532    (16,060)
Change in cash   54,488,368    (4,110,246)
Cash and cash equivalents, beginning of period   90,156,821    6,252,409 
Cash and cash equivalents, end of period  $147,339,721   $2,126,103 
           
SUPPLEMENTARY CASH FLOW DISCLOSURE          
Interest paid in cash  $18,584   $10,506 
Interest received   696,736    44,537 
Share issue costs in accounts payable   137,516    - 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

5

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2026

Expressed in Canadian Dollars (unaudited)

 

 

1. NATURE AND CONTINUANCE OF OPERATIONS

 

Draganfly Inc. (the “Company”) was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia). The Company creates unmanned and remote data collection and analysis platforms and systems that are designed to revolutionize the way companies do business. The Company’s shares trade on the following stock exchanges: NASDAQ: DPRO; CSE: DPRO; FSE: 3U8. The Company’s head office is located at 235 103rd St. E, Saskatoon, SK, S7N 1Y8 and its registered office is located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7.

 

Recognized as being at the forefront of UAV (“unmanned aerial vehicle”) technology for over two decades, Draganfly is an award-winning, industry-leading manufacturer, contract engineering, and product development company within the commercial UAV space serving the public safety, civil, military, agriculture, industrial inspections, and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.

 

2. BASIS OF PREPARATION

 

Statement of Compliance

 

These condensed consolidated interim financial statements have been prepared in accordance with International Accounting Standard (“IAS”) 34, “Interim Financial Reporting”. The Company has prepared these financial statements on the basis that it will continue to operate as a going concern. These condensed consolidated interim financial statements include all necessary disclosures required for interim financial statements but do not include all disclosures required for annual financial statements. These condensed consolidated interim financial statements should be read in conjunction with the Company’s annual financial statements for the year ended December 31, 2025.

 

These condensed consolidated interim financial statements were authorized for issue by the Board of Directors on May 11, 2026.

 

Basis of consolidation

 

Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continues to be consolidated until the date when such control ceases.

 

The condensed consolidated interim financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

 

Name of Subsidiary  Place of Incorporation  Ownership Interest 
Draganfly Innovations Inc. (DII)  Canada   100%
Draganfly Innovations USA, Inc. (DI USA)  US   100%
Dronelogics Systems Inc. (“Dronelogics”)  Canada   100%

 

All intercompany balances and transactions were eliminated on consolidation.

 

2. BASIS OF PREPARATION (CONTINUED)

 

Reclassification

 

Certain prior year amounts have been reclassified to conform to the fiscal 2026 presentation. Overall results were not impacted by the reclassification of items within the Operating Expenses of the Consolidated Statements of Comprehensive Loss. For the quarter ended March 31, 2025 the reclassified amounts were as follows:

 

   Before   Adjustment   After 
   March 31, 2025 
   Before   Adjustment   After 
Professional fees  $790,177   $(375,057)  $415,120 
Office and miscellaneous  $537,689   $166,830   $704,519 
Employee and management expenses  $1,641,319   $208,227   $1,849,546 

 

6

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2026

Expressed in Canadian Dollars (unaudited)

 

 

3. MATERIAL ACCOUNTING POLICY INFORMATION, ESTIMATES, AND JUDGEMENTS

 

These condensed consolidated interim financial statements have been prepared following the same accounting principles and methods of computation as outlined in the Company’s consolidated financial statements for the year ended December 31, 2025. A description of the accounting standards and interpretations that have been adopted by the Company can be found in the notes of the annual consolidated financial statements for the year ended December 31, 2025.

 

The preparation of the condensed consolidated interim financial statements requires management to make assumptions and estimates that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of income and expenses during the reporting period. These condensed consolidated interim financial statements include estimates, which by their nature, are uncertain. These assumptions and associated estimates are based on historical experience and other factors that are considered to be relevant. As such, actual results may differ from estimates and the effect of such differences may be material. Significant estimates and judgements used in the preparation of these condensed consolidated interim financial statements remained unchanged from those disclosed in the Company’s annual consolidated financial statements for the year ended December 31, 2025.

 

4. RECEIVABLES

 

As at  March 31, 2026   December 31, 2025 
Trade accounts receivable  $822,660   $947,939 
Sales tax receivable   334,262    93,643 
Trade and other receivables, net   $1,156,922   $1,041,582 

 

The average trade credit allowed on the sale of goods is between 30 and 60 days from the date of shipment. Sales that require deposits are typically agreed to in advance to mitigate the potential for default.

 

The Company has recognized an allowance for doubtful trade receivables on accounts that are past due by more than 31 days based on best estimates of future expected credit losses and estimated irrecoverable amounts determined by reference to past experiences.

 

In determining the recoverability of a trade receivable, the Company considers any change in the credit quality of the trade receivable from the date credit was initially granted up to the end of the reporting year. The concentration of credit risk is limited due to the fact that the customer base is diversified. The provision for expected credit losses is as follows:

 

Provision for doubtful accounts

 

Balance at December 31, 2024  $(429,506)
Additional amounts provided for during the year   (302,067)
Trade receivables written off during the year   186,211 
Foreign exchange   6,933 
Balance at December 31, 2025   (538,429)
Additional amounts provided for during the period   (15,217)
Foreign exchange   (2,802)
Balance at March 31, 2026   (556,448)

 

During the three months ended March 31, 2026, the Company recorded a provision for doubtful accounts of $15,217 (2025 – $26,703).

 

7

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2026

Expressed in Canadian Dollars (unaudited)

 

 

4. RECEIVABLES (CONTINUED)

 

The Company assumes that the credit risk on a financial asset has increased if it is outstanding beyond the agreed payment terms. The Company considers a receivable to be in default when the customer is unlikely to pay its obligations to the Company in full. The carrying amount of a receivable is written off (either partially or in full) to the extent that there is no realistic prospect of recovery.

 

Indicators that there is no reasonable expectation of recovery include, amongst others, business failure, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments over the negotiated contract period.

 

5. INVENTORY

  

As at  March 31, 2026   December 31, 2025 
Finished goods  $5,351,788   $2,233,225 
Work in process   97,476    107,287 
Raw materials   2,262,548    1,562,627 
Inventories  $7,711,812   $3,903,139 

 

During the three months ended March 31, 2026, $1,833,250 (2025 - $1,071,164) of inventory was recognized in cost of sales including an allowance for obsolete and slow-moving inventory of $105,840 (2025 – recovery of allowance for obsolete and slow-moving inventory$38,666).

 

Cost of sales consist of the following:

 

For the three months ended  March 31, 2026   March 31, 2025 
Inventory  $1,833,250   $1,071,164 
Consulting and services   34,357    24,389 
Other   96,985    142,074 
Cost of sales  $1,964,592   $1,237,627 

 

6. PREPAIDS AND DEPOSITS

  

As at  March 31, 2026   December 31, 2025 
Insurance  $315,281   $526,555 
Prepaid other   487,956    214,493 
Deposits   2,553,219    4,016,052 
Prepaid expenses and deposits  $3,356,456   $4,757,100 

 

8

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2026

Expressed in Canadian Dollars (unaudited)

 

 

7. EQUIPMENT

 

   Computer Equipment   Furniture and Equipment   Leasehold Improvements   Vehicles   Total 
Cost                         
Balance at December 31, 2024  $130,328   $997,416   $88,889   $60,343   $1,276,976 
Additions   62,145    908,221    1,300    -    971,666 
Disposals   (28,031)   (135,046)   (38,266)   -    (201,343)
Balance at December 31, 2025   164,442    1,770,591    51,923    60,343    2,047,299 
Additions   33,523    188,420    -    -    221,943 
Disposals   -    (131,832)   -    -    (131,832)
Foreign exchange   73    9,744    -    -    9,817 
Balance at March 31, 2026  $198,038   $1,836,923   $51,923   $60,343   $2,147,227 
                          
Accumulated depreciation                         
Balance at December 31, 2024  $92,676   $591,603   $24,635   $38,520   $747,434 
Charge for the year   41,903    205,491    12,568    6,546    266,508 
Disposals   (24,246)   (121,765)   (12,706)   -    (158,717)
Balance at December 31, 2025   110,333    675,329    24,497    45,066    855,225 
Charge for the period   10,152    83,880    2,771    1,146    97,949 
Disposals   -    (120,533)   -    -    (120,533)
Foreign exchange   5    489    -    -    494 
Balance at March 31, 2026  $120,490   $639,165   $27,268   $46,212   $833,135 
                          
Net book value:                         
December 31, 2025  $54,109   $1,095,262   $27,426   $15,277   $1,192,074 
March 31, 2026  $77,548   $1,197,758   $24,655   $14,131   $1,314,092 

 

Depreciation commences when assets are available for use. Depreciation expense for the quarter ended March 31, 2026 in the amount of $2,317 (2025 - $31,895) is included in the cost of sales.

 

8. RIGHT OF USE ASSETS

 

The Company has three leases with expiration dates of May 31, 2026, January 31, 2027, and September 30, 2028.

 

   Total 
Cost     
Balance at December 31, 2025 and March 31, 2026  $1,455,039 
      
Accumulated depreciation     
Balance at December 31, 2024  $1,082,695 
  Charge for the year   142,728 
Balance at December 31, 2025  $1,225,423 
  Charge for the period   35,681 
Balance at March 31, 2026  $1,261,104 
      
Net book value:     
December 31, 2025  $229,616 
March 31, 2026  $193,935 

 

9

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2026

Expressed in Canadian Dollars (unaudited)

 

 

8. RIGHT OF USE ASSET (CONTINUED)

 

Depreciation expense for the period ended March 31, 2026 in the amount of $586 (2025 - $nil) is included in the cost of sales.

 

   March 31, 2026   December 31,2025 
Buildings  $193,935   $229,616 

 

9. LEASE LIABILITIES

 

The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 11.7% to 13.3%.

 

   Total 
Balance at December 31, 2024  $428,021 
Interest expense   36,711 
Lease payments   (190,857)
Balance at December 31, 2025   273,875 
Interest expense   6,742 
Lease payments   (47,714)
Balance at March 31, 2026  $232,903 

 

Which consists of:

 

    March 31, 2026    December 31, 2025 
Current lease liability  $125,926   $143,624 
Non-current lease liability   106,977    130,251 
Ending balance  $232,903   $273,875 

 

 

Maturity analysis  March 31, 2026   December 31, 2025 
Less than one year  $143,889   $165,022 
One to three years   114,991    141,519 
Total undiscounted lease liabilities  $258,880   $306,541 
Amount representing interest   (25,977)   (32,666)
Lease liability  $232,903   $273,875 

 

Variable lease payments of $47,337, (2025 – $28,807) have been recognized in profit and loss.

 

10. TRADE PAYABLES AND ACCRUED LIABILITIES

 

As at  March 31, 2026   December 31, 2025 
Trade accounts payable  $1,138,666   $667,396 
Accrued liabilities   3,121,581    2,729,947 
Trade payables and accrued liabilities  $4,260,247   $3,397,343 

 

10

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2026

Expressed in Canadian Dollars (unaudited)

 

 

11. DEFERRED INCOME

 

At times, the Company may take payment in advance for services to be rendered. These amounts are held and recognized as services are rendered.

 

   March 31, 2026   December 31, 2025 
Deferred, revenue beginning  $209,748   $86,681 
Revenue recognized   (65,364)   (90,781)
Unearned revenues received   67,960    223,426 
Foreign exchange   1,747    (9,577)
Deferred income gross  $214,091   $209,749 
Current portion  $176,663   $165,237 
Long term portion   37,428    44,512 
Deferred Income net  $214,091   $209,749 

 

Deferred revenue of $176,663 as of March 31, 2026 is expected to be recognized as revenue within one year. The remaining is related to long-term support and maintenance arrangements and will be recognized according to the terms of these arrangements over the next 1.9 years.

 

12. SHARE CAPITAL

 

Authorized share capital

 

Unlimited number of common shares without par value.

 

Issued share capital

 

During the three months ended March 31, 2026,

 

On February 23, 2026, the Company issued 5,030,000 common shares and 2,120,000 pre-funded warrants in a financing for $68,277,951 with share issue costs of $8,136,847 ($5,724,416 allocated to equity and $2,412,431 to expense), including $2,976,520 related to broker warrants, for net proceeds of $60,141,104. The value of the issuance was allocated $48,033,503 to common shares and $20,244,448 to the pre-funded warrants as a derivative liability. The pre-funded warrants were fully exercised by March 31, 2026 using the cashless exercise option.

 

During the year ended December 31, 2025,

 

The Company issued 216,738 common shares for the vesting of restricted share units.
On May 5, 2025, the Company issued 1,715,000 units consisting of one common share and one warrant in a financing for $4,973,404 with share issue costs of $829,316, including $163,757 related to broker warrants, for net proceeds of $4,144,088. The value of the issuance was allocated $4,545,997 to the shares and $427,407 to the warrants based on the residual method. This issuance included an overallotment of 100,000 warrants convertible to 100,000 shares.
The Company issued 100,000 shares related to the overallotment of the May 5, 2025 share issuance for gross proceeds of $294,000 with share issue costs of $28,030 for net proceeds of $265,970.
On June 12, 2025 the Company issued 5,500,000 units consisting of one common share and one warrant in a financing for $18,758,889 with share issue costs of $2,258,143, including $632,798 related to broker warrants, for net proceeds of $16,500,747. The value of the issuance was allocated $18,082,472 to the shares and $676,418 to the warrants based on the residual method.
On July 21, 2025 the Company issued 4,672,895 units consisting of one common share and one warrant in a financing for $34,279,276 with share issue costs of $4,100,807, including $1,429,172 related to broker warrants, for net proceeds of $30,178,469. The warrants were valued at $nil based on the residual method.
11,712,347 shares were issued for the exercise of warrants
The Company incurred share issue costs of $140,000 related to the June 30, 2023 base shelf prospectus and included in share issuance costs.

 

11

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2026

Expressed in Canadian Dollars (unaudited)

 

 

12. SHARE CAPITAL (CONTINUED)

 

Stock Options

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees, and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 15% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion.

 

As at March 31, 2026, the Company had the following outstanding and exercisable options:

 

Grant Date  Expiry Date  Exercise Price   Remaining Contractual Life (years)   Number of Options Outstanding   Number of Options Exercisable 
October 30, 2019  October 30, 2029  $62.50    3.58    10,464    10,464 
April 30, 2020  April 30, 2030  $62.50    4.07    240    240 
April 30, 2020  April 30, 2030  $96.25    4.07    4,400    4,400 
November 24, 2020  November 24, 2030  $62.50    4.64    1,280    1,280 
February 2, 2021  February 2, 2031  $330.00    4.83    1,200    1,200 
April 27, 2021  April 27, 2031  $253.75    5.06   3,640   3,640
September 9, 2021  September 9, 2026  $121.00    0.44    1,034    1,034 
November 9, 2023  November 9, 2033  $15.75    7.60    1,200    1,200 
                 23,458    23,458 

 

  

   Number of Options   Weighted Average Exercise Price 
Outstanding, December 31, 2024   31,604   $112.05 
Forfeited   (3,746)   113.55 
Expired   (4,000)   80.00 
Outstanding, December 31, 2025   23,858   $116.34 
Forfeited   (400)   347.50 
Outstanding, March 31, 2026   23,458   $112.39 

 

No options were granted by the Company during the three months ended March 31, 2026.

 

During the three months ended March 31, 2026, the Company recorded $nil (2025 – $1,013) in stock-based compensation in relation to the vesting of stock options.

 

12

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2026

Expressed in Canadian Dollars (unaudited)

 

 

12. SHARE CAPITAL (CONTINUED)

 

Restricted Share Units

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees and technical consultants to the Company, restricted stock units (RSUs). The number of RSUs awarded and underlying vesting conditions are determined by the Board of Directors in its discretion. RSUs will have up to a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 15% (in the aggregate) of the issued and outstanding common shares from time to time.

 

As at March 31, 2026, the Company had the following RSUs outstanding:

 

   Number of RSUs 
Outstanding, December 31, 2024   188,100 
Vested   (216,738)
Issued   450,964 
Forfeited   (9,175)
Outstanding, December 31, 2025 and March 31, 2026   413,151 

 

Each RSU is exercisable into one common share of the Company upon the vesting conditions being met for a period of eighteen months to 3 years from the grant date.

 

During the three months ended March 31, 2026, the Company recorded share-based payment expense of $244,064 (2025 - $287,869) for RSUs, based on the fair values of RSUs granted which were calculated using the closing price of the Company’s stock on the day prior to grant.

 

Warrants

 

During the three months ended March 31, 2026 the Company issued pre-funded warrants (“USD pre-funded Warrants”) where a portion of the funds related to the eventual exercise have already been received with the remaining exercise price in USD. As the pre-funded warrants have a cashless exercise option and were not issued in exchange for services, the value related to the future exercise price of the USD pre-funded Warrants are required to be recorded as a financial liability and not as equity. As a financial liability, the portion of the USD pre-funded Warrants related to the future exercise price will be revalued on a quarterly basis to fair market value with the change in fair value being recorded in profit or loss. The Company valued the prefunded warrants in relation to the Company’s share price as the exercise price of the prefunded warrants was nominal.

 

13

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2026

Expressed in Canadian Dollars (unaudited)

 

 

12. SHARE CAPITAL (CONTINUED)

 

2026 issuances  February issuance 
   Broker 
Volatility   137.94%
Risk free rate   3.45%
Expected life   3 years 
Expected dividend yield   0%

 

2025 issuances  May  Issuance   June Issuance   July Issuance 
   Broker   Broker   Broker 
Volatility   122.15%   125.42%   131.17%
Risk free rate   3.63%   3.85%   3.89%
Expected life   3 years    3 years    3 years 
Expected dividend yield   0%   0%   0%

 

Warrant Derivative Liability

 

Balance at December 31, 2024  $2,198,121 
Exercised   (4,353,939)
Change in fair value of warrants outstanding   2,648,288 
Balance at December 31, 2025  $492,470 
Pre-funded warrants issued   20,244,448 
Warrants and pre-funded warrants exercised   (19,360,086)
Change in fair value of warrants and pre-funded outstanding   (1,047,731)
Balance at March 31, 2026  $329,101 

 

Details of liability warrants and their fair values are as follows:

  

Issue Date  Exercise Price   Number of Warrants Outstanding at March 31, 2026    Fair Value at March 31, 2026   Number of Warrants Outstanding at December 31, 2025    Fair Value at December 31, 2025 
Derivative Liability                         
February 26, 2024 (1)  US$4.4025    60,715   $329,101    61,911   $492,470 
February 23, 2026 (2)  $ 0.00014    -    -    -    - 
         60,715   $329,101    61,911   $492,470 

  

1)The warrants expire February 26, 2029.
2)These warrants were exercised during the quarter ended March 31, 2026

 

14

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2026

Expressed in Canadian Dollars (unaudited)

 

 

12. SHARE CAPITAL (CONTINUED)

 

The fair values of the broker warrants were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions:

 

 SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS 

   March 31, 2026   December 31, 2025 
Risk free interest rate   3.66%   3.55%
Expected volatility   140.00%   139.39%
Expected life   2.91 years    3.16 years 
Expected dividend yield   0%   0%

 

The weighted average remaining contractual life of warrants outstanding as of March 31, 2026, was 2.9 years (2025 – 4.5 years).

  

   Number of Warrants   Weighted Average Exercise Price 
Outstanding, December 31, 2024   3,717,502   $5.16 
Issued   12,587,289    5.81 
Exercised   (11,712,348)   4.80 
Outstanding, December 31, 2025    4,592,443   $6.90 
Issued   2,477,500    11.97 
Exercised   (2,121,196)   0.0037 
Outstanding, March 31, 2026   4,948,747   $7.27 

 

As at March 31, 2026, the Company had the following warrants outstanding:

 

Date issued  Expiry date  Exercise price   Number of warrants outstanding 
October 30, 2023  October 30, 2026  $23.20    12,800 
February 26, 2024  February 26, 2029  US$4.4025    60,715 
May 5, 2025  May 5, 2030  $3.9779    7,500 
June 12, 2025  June 12, 2030  $5.0768    1,014,500 
July 21, 2025  July 21, 2030  $7.3579    3,495,732 
February 23, 2026  February 23, 2029  $11.9744    357,500 
            4,948,747 

 

The weighted average remaining contractual life of warrants outstanding as of March 31, 2026, was 4.16 years (December 31, 2025 – 4.5 years).

 

13.SEGMENTED INFORMATION

 

As at and for the three months ended March 31, 2026 the Company operates in 2 reportable segments (as at and for the year ended December 21, 2025 – 2). The Company organizes its two segments based on its product line as well as a corporate segment. The two segments are Drones and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV) while the Corporate segment includes all costs not directly associated with the Drone segment. The Company aggregates the information for the segments by analyzing the revenue stream and allocating direct costs to that respective segment. The Corporate segment is aggregated by relying on the entity that includes corporate costs (Draganfly Inc.).

 

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker.

 

15

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2026

Expressed in Canadian Dollars (unaudited)

 

 

13. SEGMENTED INFORMATION (CONTINUED)

 

The board of the Company relies on executive management which assesses the financial performance and position of the group and makes strategic decisions. Executive management, which has been identified as being the chief operating decision maker, consists of the chief executive officer, chief operating officer and chief financial officer.

 

March 31, 2026  Drones   Corporate   Total 
Sales of goods  $2,232,132   $-   $2,232,132 
Provision of services   80,221    -    80,221 
Total revenue   2,312,353    -    2,312,353 
Segment loss    430,012    3,244,075    3,674,087 
Finance and other costs   678,152    -    678,152 
Depreciation   120,536    715    121,251 
Amortization   1,805    -    1,805 
Change in fair value of derivative liability   -    1,047,731    1,047,731 
Write down of inventory (note 5)   105,840    -    105,840 
Net loss for the period  $1,336,345   $4,292,521   $5,628,866 

 

March 31, 2025  Drones   Corporate   Total 
Sales of goods  $1,541,811   $-   $1,541,811 
Provision of services   5,904    -    5,904 
Total revenue   1,547,715    -    1,547,715 
Segment loss   1,872,918    1,295,088    3,168,006 
Finance and other costs   34,031    -    34,031 
Depreciation   72,221    3,195    75,416 
Amortization   2,257    -    2,257 
Change in fair value of derivative liability   -    157,830    157,830 
Loss on write-off of notes receivable   -    25,951    25,951 
Recovery of write down of inventory (note 5)   (38,666)   -    (38,666)
Net loss for the period  $1,942,761   $1,482,064   $3,424,825 

 

Geographic revenue is measured by aggregating sales based on the country and the entity where the sale was made.

 

   March 31, 2026   December 31, 2025 
Non-current assets          
Canada  $940,435   $980,758 
United States   630,470    548,473 
   $1,570,905   $1,529,231 

 

   2026   2025 
   For the three months ended  March 31, 
   2026   2025 
Revenue        
Canada  $2,308,375   $1,544,083 
United States   3,978    3,632 
Revenue  $2,312,353   $1,547,715 

 

16

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2026

Expressed in Canadian Dollars (unaudited)

 

 

14. OFFICE AND MISCELLANEOUS 

  

   2026   2025 
   For the three months ended March 31, 
   2026   2025 
Advertising, marketing, and investor relations  $528,214   $223,984 
Compliance fees   115,631    79,095 
Business development   572,589    53,908 
General freight   118,827    69,250 
Subscription, membership & IT support   182,181    57,773 
General office   368,666    220,509 
Office and Miscellaneous Expenses  $1,886,108   $704,519 

 

15. OTHER EXPENSE

  

   2026   2025 
   For the three months ended March 31, 
   2026   2025 
Share issue costs  $2,412,431   $- 
Write off of accounts (payable) receivable   15,217    (24,473)
Other   (200)   23 
Total Other expenses  $2,427,448   $(24,450)

 

16. RELATED PARTY TRANSACTIONS

 

On August 1, 2019, the Company entered in a business services agreement (the “Agreement”) with Business Instincts Group (“BIG”), a company that Cameron Chell, CEO and director has a material interest in that he previously controlled, to provide: corporate development and governance, strategic facilitation and management, general business services, office space, corporate business development video content, website redesign and management, and online visibility management. The services are provided by a team of consultants and the costs of all charges are based on the fees set in the Agreement. For the three months ended March 31, 2026, the Company incurred fees of $99,577 (2025 - $93,283). As at March 31, 2026, the Company was indebted to this company in the amount of $nil (2025 - $9,524).

 

On October 1, 2019, the Company entered into an independent consultant agreement (“Consultant Agreement”) with 1502372 Alberta Ltd, a company controlled by Cameron Chell, CEO and director, to provide executive consulting services to the Company. The costs of all charges are based on the fees set in the Consultant Agreement. For the three months ended March 31, 2026, the Company incurred fees of $155,193 (2025 - $104,226). As at March 31, 2026, the Company was indebted to this company in the amount of $nil (2025 - $nil).

 

On July 3, 2020, the Company entered into an executive consultant agreement (“Executive Agreement”) with Scott Larson, a director of the Company, to provide executive consulting services, as President, to the Company. On May 9, 2022, Scott Larson ceased to be President of the Company and entered into an agreement to provide executive consulting services to the Company and all fees are set in the consulting agreement. For the three months ended March 31, 2026, the Company incurred fees of $61,666 (2025 - $2,861). As of January 19, 2026 the contract for consulting services was terminated.

 

For the three months ended March 31, 2026 and 2025 salary and commissions were paid to family members of key management. In addition, during 2025, one family member was paid as a contractor prior to becoming an employee. The amounts paid for March 31, 2026 were $76,795 (2025 - $19,053).

 

17

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2026

Expressed in Canadian Dollars (unaudited)

 

 

16. RELATED PARTY TRANSACTIONS (CONTINUED)

 

As at March 31, 2026, the Company had $117,309 (2025 - $155,475) payable to related parties that was included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

 

Key management compensation

 

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the three months ended March 31, 2026 and 2025 included:

 

   2026   2025 
   For the three months ended March 31, 
   2026   2025 
Director fees  $119,498   $132,651 
Salaries   371,908    217,510 
Share-based payments   150,360    194,200 
Total  $641,766   $544,361 

 

Other related party transactions

 

   2026   2025 
   For the three months ended March 31, 
   2026   2025 
Management fees paid to a company controlled by CEO and director  $155,193   $104,226 
Management fees paid to a company that the CEO holds an economic interest in   99,577    93,283 
Salary and commission paid to family of key management   76,795    19,053 
Management fees paid to a company controlled by a director   61,666    2,861 
Management fees paid to a company, total   $393,231   $219,423 

 

17. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

 

The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board of Directors approves and monitors the risk management processes, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

 

Credit risk

 

Credit risk is the risk that of an unexpected loss if a customer or third party fails to meet its contractual obligations.

 

The Company is subject to credit risk on its cash and receivables. The Company limits its exposure to credit loss on cash by placing its cash with a high-quality financial institution. The Company performs credit evaluations of its customers to reduce the credit risk of receivable balances.

 

18

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2026

Expressed in Canadian Dollars (unaudited)

 

 

17. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONTINUED)

 

Receivables

 

Receivables primarily consist of trade receivables, accrued receivables and taxes receivable. The Corporation’s exposure to credit risk is associated with trade receivables and the potential risk that any customer is unable to pay amounts due. Allowances for doubtful accounts and bad debts are estimated as at the balance sheet date. The amounts reported for trade receivables on the balance sheet are net of allowances for doubtful accounts and the net carrying value represents the Corporation’s maximum exposure to credit risk.

 

Management reviews past due trade receivables balances on a continuous basis to monitor potential credit risks. Accounts are considered for impairment on a case-by-case basis when they are past due or when objective evidence is received that a customer may default. A number of factors are considered in determining the likelihood of impairment. All bad debt write-offs and changes in the doubtful trade receivables reserve are expensed or credited, as applicable, to selling expenses in the condensed consolidated interim statement of comprehensive loss.

 

Draganfly believes that credit risk associated with its trade receivables is limited for the following reasons:

 

Trade receivables balances are spread amongst a broad customer base;
The aging profile of trade receivables balances is systematically monitored by management; and
Payments for larger orders are requested at least partially in advance of products being shipped

 

Foreign exchange risk

 

Foreign currency risk is the risk that the fair values of future cash flows of a financial instrument will fluctuate because they are denominated in currencies that differ from the respective functional currency. The Company does not hedge its exposure to fluctuations in foreign exchange rates.

 

The following table summarizes the sensitivity of the fair value of the Company’s risk to foreign exchange rates, with all other variables held constant. Fluctuations of 10 percent in the foreign exchange rate between US dollars and Canadian dollars could have resulted in a change impacting net loss upon consolidation as follows:

   March 31, 2026   March 31, 2025 
   USD   Change in currency   Effect on after tax loss   USD   Change in currency   Effect on after tax loss 
Net monetary assets  $103,619,836    10%  $14,479,030   $1,299,964    10%  $210,406 
Net monetary liabilities   (532,842)   10%   (74,273)   (111,440)   10%   (16,022)

 

Fair value

 

A number of the Company’s accounting policies and disclosures require the measurement of fair values for financial assets and liabilities. The Company has established a control framework with respect to the measurement of fair values. Fair values are categorized into different levels of a fair value hierarchy based on the inputs used in the valuation techniques as follows:

 

Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.

Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.

Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.

 

Cash, equity securities in investee companies and warrants are measured at fair value. The financial assets and liabilities measured at fair value by hierarchy are shown in the table below. The amounts shown are based on the amounts recognized in the condensed consolidated interim statements of financial position. These financial assets and liabilities are measured at fair value through profit and loss.

 

March 31, 2026  Level 1   Level 3   Total 
Cash  $147,339,721   $-   $147,339,721 
Equity securities in investee companies   28,571    -    28,571 
Derivative liability   -    (329,101)   (329,101)
Total  $147,368,292   $(329,101)  $147,039,191 

 

December 31, 2025  Level 1   Level 3   Total 
Cash  $90,156,821   $-   $90,156,821 
Equity securities in investee companies   71,429    -    71,429 
Derivative liability   -    (492,470)   (492,470)
Total  $90,228,250   $(492,470)  $89,735,780 

 

19

 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three Months Ended March 31, 2026

Expressed in Canadian Dollars (unaudited)

 

 

17. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONTINUED)

 

The following table shows the valuation techniques used in measuring Level 3 fair values for the derivative liability as well as the significant unobservable inputs used.

 

 

Type

 

 

Valuation technique

 

 

Key inputs

  Inter-relationship between significant inputs and fair value measurement
Warrant derivative liability   The fair value of the warrants derivative liability at initial recognition and at year end has been calculated using the Black Scholes Option Pricing Model  

Key observable inputs

● Share price

● Risk free interest rate

● Dividend yield

Key unobservable inputs

● Expected volatility

 

The estimated fair value would increase (decrease) if:

● The price was higher (lower)

● The risk-free rate was higher (lower)

● The dividend yield was lower (higher)

● The expected volatility was higher (lower)

 

For the fair value of the derivative liability, reasonable possible changes to the expected volatility, the most significant unobservable input would have the following effects:

 

     Impact on comprehensive loss 
Unobservable Inputs  Change   Three months ended March 31, 2026   Year ended December 31, 2025 
Volatility   20%  $22,330   $25,437 

 

18. SUBSEQUENT EVENT

 

On April 15, 2026 the company granted 2,011,903 RSU’s to employees, executives and directors with a total value of $8.4 million. 1,320,445 of the RSU’s issued to executives have performance criteria for vesting to occur.

 

 

20